When to Consider a Clinical Trial?
Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease.
Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease. In this video, leading CTCL experts address the question of when a patient should consider entering a clinical trial.
The video features expert insights from:
- Larisa Geskin, MD, Associate Professor of Dermatology, University of Pittsburgh
- Stuart Lessin, MD, Medical Director, KGL Skin Study Center, Broomall, PA
- Pierluigi Porcu, MD, Associate Professor of Internal Medicine, Division of Hematology-Oncology, Ohio State University Comprehensive Cancer Center
- Marianne Tawa, RN, MSN, ANP, Nurse Practitioner, Dermatology and Cutaneous Oncology, Dana Farber Cancer Institute
This video is one of several featured in the CLF’s Online Learning Center. Other topics include recommendations for managing itch and a three-part overview of treatments for cutaneous lymphoma.
For more information, visit http://www.clfoundation.org/online-learning-center.
FDA Grants Pirtobrutinib Accelerated Approval to Treat CLL/SLL in the Third Line
December 2nd 2023The FDA has approved the non-covalent BTK inhibitor, pirtobrutinib, to treat patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have already undergone 2 lines of therapy.
